Latest Asx News

DevEx Resources has secured nine uranium exploration licences from Rio Tinto in the Northern Territory’s Alligator Rivers Uranium Province, significantly enlarging its exploration territory near historic high-grade deposits.

TPG Telecom has launched a $138 million Retail Reinvestment Plan, allowing eligible shareholders to reinvest proceeds from a $3 billion capital return. This initiative complements a $300 million institutional plan, aiming to reduce debt and enhance shareholder value.

EVE Health Group has partnered with telehealth provider hubMed to deliver a national patient support program, enhancing care continuity for users of its women’s and men’s health products Dyspro™ and Libbo™.

The Takeovers Panel has declared unacceptable circumstances in the Mayne Pharma acquisition after Cosette Pharmaceuticals changed its intentions to close the Salisbury manufacturing site, raising concerns over market transparency and regulatory approval.

The Takeovers Panel has declared unacceptable circumstances in the Mayne Pharma acquisition, ordering Cosette Pharmaceuticals to comply with conditions preventing closure of the Salisbury manufacturing site. This ruling highlights concerns over market transparency and the integrity of the takeover process.

Mount Hope Mining has withdrawn its recently announced Share Purchase Plan, citing challenging market conditions. Shareholders will receive full refunds within days.

Global X Management (AUS) Limited has announced estimated distribution amounts for three of its ETFs listed on the ASX AQUA Market for the period ending 30 November 2025, highlighting income opportunities for investors.

I Synergy Group’s subsidiary has inked four separate 12-month leases for its AI computing hardware and software, marking a strategic push into recurring revenue streams.

Astron Limited has received a pivotal Australian Taxation Office Class Ruling confirming capital gains tax roll-over relief for shareholders following its redomicile from Hong Kong to Australia. This development streamlines the company’s structure and offers potential long-term benefits to investors.

Bentley Capital Limited has reached a confidential settlement with Keybridge Capital Limited, receiving $250,000 to resolve a protracted legal dispute over shared legal costs.

Altamin Limited has appointed GBA Capital as lead manager to place shortfall shares from its recent entitlement offer, offering broker options as part of the arrangement. This move aims to bolster support for its critical minerals projects in Italy while engaging new and existing investors.

Bio-Gene Technology Limited updates on its development of two novel insecticides, Flavocide and Qcide, highlighting regulatory progress, commercial partnerships, and a strong market outlook across multiple sectors.